神经损伤与功能重建
神經損傷與功能重建
신경손상여공능중건
Neural Injury and Functional Reconstruction
2015年
6期
474-476
,共3页
智孔亮%辛娜%曹志红%卢丽敏
智孔亮%辛娜%曹誌紅%盧麗敏
지공량%신나%조지홍%로려민
细胞外基质金属蛋白酶诱导因子%人神经母细胞瘤细胞株%泛素 - 蛋白酶体
細胞外基質金屬蛋白酶誘導因子%人神經母細胞瘤細胞株%汎素 - 蛋白酶體
세포외기질금속단백매유도인자%인신경모세포류세포주%범소 - 단백매체
extracellular matrix metalloproteinase inducer%SH-SY5Y%ubiquitin-proteasome system
目的:探讨细胞外基质金属蛋白酶诱导因子在 SH-SY5Y 细胞中的表达及其与泛素表达的定位关系。方法:采用不同浓度的 MG-132蛋白酶体抑制剂(0、0.5、1、2.5和5μmol/L)处理体外培养人神经母细胞瘤细胞株 SH-SY5Y 细胞。处理24 h 后,采用 In-cell Western 法和 Western Blot 法检测 SH-SY5Y 细胞中 CD147蛋白的表达,采用免疫荧光双标法检测 CD147和泛素的共表达。结果:不同浓度的 MG-132蛋白酶体抑制剂处理 SH-SY5Y 细胞,CD147蛋白的含量呈浓度依赖性增加。当抑制剂浓度为5μmol/L 时,CD147的含量明显高于抑制剂浓度为0μmol/L 组,差异有统计学意义(P<0.05)。SH-SY5Y 细胞中同时存在 CD147和泛素的表达,而且存在共表达部位。结论:CD147可能通过泛素-蛋白酶体途径降解。
目的:探討細胞外基質金屬蛋白酶誘導因子在 SH-SY5Y 細胞中的錶達及其與汎素錶達的定位關繫。方法:採用不同濃度的 MG-132蛋白酶體抑製劑(0、0.5、1、2.5和5μmol/L)處理體外培養人神經母細胞瘤細胞株 SH-SY5Y 細胞。處理24 h 後,採用 In-cell Western 法和 Western Blot 法檢測 SH-SY5Y 細胞中 CD147蛋白的錶達,採用免疫熒光雙標法檢測 CD147和汎素的共錶達。結果:不同濃度的 MG-132蛋白酶體抑製劑處理 SH-SY5Y 細胞,CD147蛋白的含量呈濃度依賴性增加。噹抑製劑濃度為5μmol/L 時,CD147的含量明顯高于抑製劑濃度為0μmol/L 組,差異有統計學意義(P<0.05)。SH-SY5Y 細胞中同時存在 CD147和汎素的錶達,而且存在共錶達部位。結論:CD147可能通過汎素-蛋白酶體途徑降解。
목적:탐토세포외기질금속단백매유도인자재 SH-SY5Y 세포중적표체급기여범소표체적정위관계。방법:채용불동농도적 MG-132단백매체억제제(0、0.5、1、2.5화5μmol/L)처리체외배양인신경모세포류세포주 SH-SY5Y 세포。처리24 h 후,채용 In-cell Western 법화 Western Blot 법검측 SH-SY5Y 세포중 CD147단백적표체,채용면역형광쌍표법검측 CD147화범소적공표체。결과:불동농도적 MG-132단백매체억제제처리 SH-SY5Y 세포,CD147단백적함량정농도의뢰성증가。당억제제농도위5μmol/L 시,CD147적함량명현고우억제제농도위0μmol/L 조,차이유통계학의의(P<0.05)。SH-SY5Y 세포중동시존재 CD147화범소적표체,이차존재공표체부위。결론:CD147가능통과범소-단백매체도경강해。
Objective: To investigate the expression of extracellular matrix metalloproteinase inducer in SH-SY5Y cells and the spacial relationship with the expression of ubiquitin. Methods: Human neuroblastoma cell line SH-SY5Y was treated with MG-132 proteasome inhibitors at different concentrations (0, 0.5, 1, 2.5 and 5 μmol/L) in vitro. After 24 h, In-cell Western and Western Blot methods were employed to detect the expression of CD147 protein. Immunofluorescence double labeling method was used to detect the co-localization of ubiquitin and CD147. Results:When MG-132 proteasome inhibitors were used to deal with SH-SY5Y cultured in vitro, The ex-pression of CD147 protein in SH-SY5Y cells was increased with MG-132 proteasome inhibitors in a concentration dependent manner. When the inhibitor concentration was 5 μmol/L, the expression of CD147 was significantly higher than that in the control (0 μmol/L) (P<0.05). The expressions of Ubiquitin and CD147 were co-localized in SH-SY5Y cells. Conclusion: CD147 may be degraded by the ubiquitin-proteasome pathway.